Dr. Samadani Receives FDA Approval for Concussion|Detection ...

Uzma Samadani, MD, PhD - Neurotrauma Research Lab

... concussion diagnostic cleared for marketing approval by the FDA. She holds ... Samadani has received more than three million dollars in research grants ...

Oculogica Receives FDA Approval for Device Diagnosing Brain ...

Oculogica, a medical startup founded by local neurosurgeon Dr. Uzma Samadani, has received FDA approval to market its eye-tracking device as an aid for ...

Oculogica Receives FDA Marketing Approval for EyeBOX, the First ...

Oculogica Receives FDA Marketing Approval for EyeBOX, the First Noninvasive, Baseline-Free Test for Concussion ... Samadani, PhD, CEO of Oculogica, said in a ...

Oculogica's New Patent Opens Potential for a CTE Test for Live ...

Oculogica, a leader in concussion diagnosis and categorization, with the only FDA ... They received this first FDA clearance in December 2018.

How Minnetronix helped Oculogica launch its new EyeBOX ...

Less than three months after Oculogica won FDA clearance for its portable concussion diagnostic device, contract manufacturer Minnetronix is ...

Fund led by Green Bay Packers, Microsoft invests $8 million in ...

The FDA has only approved the device for use by physicians. It ... concussion clinics," Rosina Samadani said. "We're also working on a ...

Detecting Hidden Brain Injuries | Morehouse School of Medicine

But researchers are encouraged by blood tests and devices to aid in mild-TBI diagnosis that have received regulatory clearance in the past six years. “I am as ...

FDA authorizes marketing of first blood test to aid in the evaluation of ...

Availability of a blood test for concussion will help health care professionals determine the need for a CT scan in patients suspected of having ...

Uzma Samadani, MD, PhD, FACS, FAANS - U2FP

Samadani is an Associate Professor in the Department of Bioinformatics ... concussion diagnostic cleared for marketing approval by the FDA. She holds ...

"Eyes and Concussions" Casual Conversations 46 Dr. Rosina ...

Katherine Snedaker, CEO of PINK Concussions, interviews Dr. Rosina Samadani on her career, her interest in brain injury, and her role as CEO ...

Mark Jacobs on LinkedIn: Sisters Get Concussion Diagnostic ...

My smart wife & her sister rocking it again!!! Rosina S. Uzma Samadani | 12 comments on LinkedIn.

K191183 Trade/Device Name: EyeBOX Regulation

The EyeBOX is intended to measure and analyze eye movements as an aid in the diagnosis of concussion, also known as mild traumatic brain injury ...

Bedside blood concussion test, with Pitt research, finds FDA approval

A Pitt professor of neurological surgery celebrated with his team as their research cleared a major hurdle: FDA approval.

MED.00137 Eye Movement Analysis Using Non-spatial Calibration ...

... concussions. The FDA approval letter includes the following indications for use: The EyeBOX is intended to measure and analyze eye movements as an aid in ...

Spinal Cord Injury and Traumatic Brain Injury Research Grant Program

which may be necessary for FDA approval and will be essential for insurance approval. ... Principal Investigator: Dr. Uzma Samadani. Grant ...

Updating Diagnoses for Speed and Accuracy: Using AI, Cameras ...

Uzma Samadani is using technology to take the uncertainty out of concussion diagnosis. She is an associate professor of bioinformatics and ...

Vagus Nerve Stimulation to Augment Recovery from Severe ...

We recently obtained FDA approval for a pilot prospective randomized ... VNS is FDA cleared for MRI scanning; a transmit and receive head coil is used ...

Master of Athletic Training Faculty, Students' Research will Fuel ...

EyeBOX, is the first and only baseline-free, non-invasive device with FDA clearance to diagnose concussions. ... Rosina Samadani saying the ...

Dr. Peter Cummings, MD - Chair, Medical Advisory Committee

The only FDA approved test for concussion evaluation (2016) and has 13 ... Samadani has received more than three million dollars in research grants ...

New Brain Injury Tool Provides Data to Personal Injury Lawyers

... get back to “normal” or if a return to normal is even likely. Last year, however, the U.S. Food and Drug Administration (FDA) approved a new ...